Demand for non-clinical development support drives L2D expansion
This article was originally published in Scrip
Executive Summary
An increase in demand from small- and medium-sized drug development companies for non-clinical development support has led to one young CRO, Leads to Development (L2D), opening new two new offices alongside its Paris, France base.